Unbound MEDLINE

Efficacy of solifenacin for overactive bladder symptoms, symptom bother, and health-related quality of life in patients by duration of self-reported symptoms: a secondary analysis of the VIBRANT study.

Abstract

In this post-hoc analysis of data from patients with overactive bladder (OAB) in VIBRANT patients receiving solifenacin showed statistically significantly greater improvement versus placebo in most outcome measures regardless of OAB symptom duration (less than five years and five years or longer).

Links

  • Aggregator Full Text

    • Authors

    Gollar KM, Young DG, Bailen J, He W, Forero-Schwanhaeuser S

    Institution

    Metropolitan Urology, Jeffersonville, IN, USA.

    Source

    Urologic nursing 32:1 pg 38-46, 50

    MeSH

    Adult
    Female
    Humans
    Male
    Muscarinic Antagonists
    Patient Satisfaction
    Quality of Life
    Quinuclidines
    Randomized Controlled Trials as Topic
    Self Report
    Tetrahydroisoquinolines
    Treatment Outcome
    Urinary Bladder, Overactive

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22474864